EUVIMEDEUVIMED entdecken
Crossref

Association between Denosumab Therapy and Hypocalcemia: Influence of Concomitant Gastric Acid–Suppressive Agents and Other Clinical Parameters

Riho Morofuji, Kohei Oyabu, Takuya Imatoh, Yuki Yasutaka, Tadahiro Ikeuchi, Susumu Kaneshige, Keisuke Migita, Kentaro Ogata, Hidetoshi Kamimura

Biological and Pharmaceutical Bulletin · 09.07.2026 · 49 (7) · 1087-1092

DOI: 10.1248/bpb.b25-00615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 09.07.2026. Verfasst von Riho Morofuji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan. Hauptthemen laut MEDLINE: Hypocalcemia, Denosumab, Proton Pump Inhibitors, Histamine H2 Antagonists. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypocalcemiaDenosumabProton Pump InhibitorsHistamine H2 AntagonistsBone Density Conservation AgentsHumansFemaleMaleAgedMiddle AgedCalciumDrug Therapy, CombinationAged, 80 and over

Stichwörter der Autor:innen

denosumabhistamine-2 receptor antagonisthypocalcemiaproton pump inhibitor

Substanzen

DenosumabProton Pump InhibitorsHistamine H2 AntagonistsCalciumBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
  • Faculty of Pharmaceutical Sciences, Drug Informatics and Translational Research, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
  • Department of Pharmaceutical and Health Care Management, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.

Zitieren

APA

Morofuji, R., Oyabu, K., Imatoh, T., Yasutaka, Y., Ikeuchi, T., Kaneshige, S., Migita, K., Ogata, K., & Kamimura, H. (2026). Association between Denosumab Therapy and Hypocalcemia: Influence of Concomitant Gastric Acid–Suppressive Agents and Other Clinical Parameters. Biological and Pharmaceutical Bulletin, 49(7), 1087-1092. https://doi.org/10.1248/bpb.b25-00615

Vancouver

Morofuji R, Oyabu K, Imatoh T, Yasutaka Y, Ikeuchi T, Kaneshige S, et al. Association between Denosumab Therapy and Hypocalcemia: Influence of Concomitant Gastric Acid–Suppressive Agents and Other Clinical Parameters. Biological and Pharmaceutical Bulletin. 2026;49(7):1087-1092. doi:10.1248/bpb.b25-00615

BibTeX
@article{Morofuji2026,
  author = {Morofuji, Riho and Oyabu, Kohei and Imatoh, Takuya and Yasutaka, Yuki and Ikeuchi, Tadahiro and Kaneshige, Susumu and Migita, Keisuke and Ogata, Kentaro and Kamimura, Hidetoshi},
  title = {Association between Denosumab Therapy and Hypocalcemia: Influence of Concomitant Gastric Acid–Suppressive Agents and Other Clinical Parameters},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2026},
  volume = {49},
  number = {7},
  pages = {1087--1092},
  doi = {10.1248/bpb.b25-00615}
}
Kostenlos starten →